✦ LIBER ✦

Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma

✍ Scribed by Weijing Sun; Davendra Sohal; Daniel G. Haller; Kristine Mykulowycz; Mark Rosen; Michael C. Soulen; Millie Caparro; Ursina R. Teitelbaum; Bruce Giantonio; Peter J. O'Dwyer; Abraham Shaked; Rajender Reddy; Kim Olthoff

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 169 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25889

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced colorectal carcino

Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine : A Phase II trial

✍ Anthony F. Shields; Mark M. Zalupski; John L. Marshall; Neal J. Meropol 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract ## BACKGROUND The current study was designed to evaluate the antitumor activity and toxicity of capecitabine and oxaliplatin in previously untreated patients with advanced colorectal carcinoma. The primary endpoint of the study was to determine the objective response rate, and a second

Randomized controlled trial of interfero

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

✍ Josep M. Llovet; Margarita Sala; Lluís Castells; Yanette Suarez; Ramon Vilana; L 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

The aim of this randomized controlled trial was to assess the efficacy of interferon alfa-2b (IFN) for the treatment of advanced hepatocellular carcinoma (HCC). Fifty-eight patients with HCC who were not suitable for resection, transplantation, ethanol injection, or arterial embolization were strati

Phase 2 trial of oxaliplatin plus capeci

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer

✍ Henry Q. Xiong; Gauri R. Varadhachary; Joan C. Blais; Kenneth R. Hess; James L. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

A phase II trial of gemcitabine in patie

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili

Phase 1/2 study of everolimus in advance

Phase 1/2 study of everolimus in advanced hepatocellular carcinoma

✍ Andrew X. Zhu; Thomas A. Abrams; Rebecca Miksad; Lawrence S. Blaszkowsky; Jeffre 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

Oxaliplatin and capecitabine in the trea

Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site : A phase 2 trial of the Sarah Cannon Oncology Research Consortium

✍ John D. Hainsworth; David R. Spigel; Howard A. Burris III; Dianna Shipley; Cindy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views